- Home
- ADMA vs ESE Comparison
ADMA vs ESE Comparison
Compare ADMA & ESE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- ESE
- Stock Information
- Founded
- ADMA 2004
- ESE 1990
- Country
- ADMA United States
- ESE United States
- Employees
- ADMA N/A
- ESE N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- ESE Telecommunications Equipment
- Sector
- ADMA Health Care
- ESE Telecommunications
- Exchange
- ADMA Nasdaq
- ESE Nasdaq
- Market Cap
- ADMA 5.1B
- ESE 5.0B
- IPO Year
- ADMA N/A
- ESE N/A
- Fundamental
- Price
- ADMA $19.33
- ESE $191.36
- Analyst Decision
- ADMA Strong Buy
- ESE Strong Buy
- Analyst Count
- ADMA 3
- ESE 2
- Target Price
- ADMA $27.67
- ESE $187.50
- AVG Volume (30 Days)
- ADMA 2.4M
- ESE 140.4K
- Earning Date
- ADMA 08-06-2025
- ESE 08-07-2025
- Dividend Yield
- ADMA N/A
- ESE 0.17%
- EPS Growth
- ADMA N/A
- ESE 19.62
- EPS
- ADMA 0.84
- ESE 4.56
- Revenue
- ADMA $459,381,000.00
- ESE $1,071,861,000.00
- Revenue This Year
- ADMA $21.11
- ESE $17.26
- Revenue Next Year
- ADMA $25.97
- ESE $14.04
- P/E Ratio
- ADMA $23.13
- ESE $42.09
- Revenue Growth
- ADMA 62.23
- ESE 8.40
- 52 Week Low
- ADMA $10.21
- ESE $108.70
- 52 Week High
- ADMA $25.67
- ESE $198.34
- Technical
- Relative Strength Index (RSI)
- ADMA 62.08
- ESE 51.09
- Support Level
- ADMA $16.77
- ESE $185.82
- Resistance Level
- ADMA $18.41
- ESE $196.95
- Average True Range (ATR)
- ADMA 0.67
- ESE 3.59
- MACD
- ADMA 0.26
- ESE -0.37
- Stochastic Oscillator
- ADMA 96.26
- ESE 44.25
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About ESE ESCO Technologies Inc.
ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace and Defense, Utility Solutions Group (USG), and Test. The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.